Bayer Advances Parkinson’s Cell And Gene Therapies Into First Human Studies
Recently-Acquired BlueRock and AskBio Move Ahead
BlueRock's therapy will involve the implanting of stem cells deep into the brains of Parkinson's disease patients, with the hope of restoring nerve cells and function. • Source: Alamy
